In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...

The four-month-old is now waiting one hundred days to find out if the transplant was a success.

Sickle cell disease commonly affects people of African and Caribbean backgrounds and can be life-threatening but campaigners ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.

The act of donating blood itself can take as little as 10 minutes, with a brief screening process and recovery period before ...

Our blood consists of many cell types that develop through different stages from a precursor type – the blood stem cell. An ...

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or ...

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...

The sugar glucose, which is the main source of energy in almost every living cell, has been revealed in a Stanford Medicine study to also be a master regulator of tissue differentiation - the process ...